Skip to main content

Find Clinical Trials

Home
Conditions
Poliomyelitis

Clinical trial condition

Poliomyelitis

Explore clinical trials studying Poliomyelitis. Study availability and eligibility vary by location and protocol.

231 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Poliomyelitis trial results

Completed

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

NCT00611559

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: GSK Investigational Site Murmansk, Russia

GSK Investigational Site Perm, Russia

GSK Investigational Site Syktyvkar, Russia

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

NCT01086423

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Wuzhou, Guangxi, China

GSK Investigational Site Wuzhou, Guangxi, China

View Trial Details

Completed

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

NCT00627458

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Jarvenpaa, Finland

GSK Investigational Site Oulu, Finland

GSK Investigational Site Pori, Finland

GSK Investigational Site Tampere, Finland

View Trial Details

Completed

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

NCT00635128

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
Locations: GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany

GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany

View all 38 locations

View Trial Details

Completed

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

NCT01323959

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site Derval, France

GSK Investigational Site La Chapelle-Basse-Mer, France

GSK Investigational Site La Riche, France

GSK Investigational Site Nantes, France

View all 15 locations

View Trial Details

Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site Genoa, Liguria, Italy

GSK Investigational Site Milan, Lombardy, Italy

GSK Investigational Site Novara, Piedmont, Italy

GSK Investigational Site Cagliari, Sardinia, Italy

View Trial Details

Completed

Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine

NCT00325143

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Singapore

View Trial Details

Completed

Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)

NCT00964028

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Wuzhou, Guangxi, China

View Trial Details

Completed

IPV Clinical Trial - The Gambia

NCT01847872

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Medical Research Council Unit Fajara, The Gambia

View Trial Details

Completed

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

NCT00432042

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +53 more
Locations: Alsfeld, Germany

Bad Saulgau, Germany

Bad Säckingen, Germany

Bad Sobernheim, Germany

View all 50 locations

View Trial Details